Zevra Therapeutics (1GDA.F) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.65
0.21
1.08
1.94

Details

Expected EPS
1.9386631999999997
Actual EPS
1.036123
Surprise EPS
-0.9
Surprise Percent
+46.55%

Description

Zevra Therapeutics (1GDA.F) has reported earnings of 1.036123 per share for Q3 2025.

0 Comments

Share your thoughts